Metastatic melanoma (MM) is a highly mutated type of cancer and can be classified into four groups depending on the driver mutation observed—mutation in BRAF (~50% of melanomas), NRAS (~30%), NF1 (10–15%) or triple wildtype [3,13,14]. This evidence concerns the gene BRAF and melanoma.